Acrivon Therapeutics Inc. is a biopharmaceutical company focused on developing personalized oncology therapies using proprietary protein biomarker technology to predict drug response.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!